{
  "zip": "07016",
  "sector": "Healthcare",
  "longBusinessSummary": "Enzon Pharmaceuticals, Inc., together with its subsidiaries, engages in licensing drug products. Its marketed drug products include PegIntron and Sylatron. The company was founded in 1981 and is headquartered in Cranford, New Jersey.",
  "city": "Cranford",
  "phone": "732 980 4500",
  "state": "NJ",
  "country": "United States",
  "companyOfficers": [],
  "website": "http://www.enzon.com",
  "maxAge": 1,
  "address1": "20 Commerce Drive",
  "industry": "Biotechnology",
  "address2": "Suite 135",
  "previousClose": 0.336,
  "regularMarketOpen": 0.34,
  "twoHundredDayAverage": 0.19482015,
  "trailingAnnualDividendYield": null,
  "payoutRatio": 0,
  "volume24Hr": null,
  "regularMarketDayHigh": 0.34,
  "navPrice": null,
  "averageDailyVolume10Day": 759462,
  "totalAssets": null,
  "regularMarketPreviousClose": 0.336,
  "fiftyDayAverage": 0.25363636,
  "trailingAnnualDividendRate": null,
  "open": 0.34,
  "averageVolume10days": 759462,
  "expireDate": null,
  "yield": null,
  "algorithm": null,
  "dividendRate": null,
  "exDividendDate": 1569801600,
  "beta": 0.640231,
  "circulatingSupply": null,
  "startDate": null,
  "regularMarketDayLow": 0.275,
  "priceHint": 4,
  "currency": "USD",
  "regularMarketVolume": 925905,
  "lastMarket": null,
  "maxSupply": null,
  "openInterest": null,
  "marketCap": 23377598,
  "volumeAllCurrencies": null,
  "strikePrice": null,
  "averageVolume": 227738,
  "priceToSalesTrailing12Months": 348.91937,
  "dayLow": 0.275,
  "ask": 1.41,
  "ytdReturn": null,
  "askSize": 200,
  "volume": 925905,
  "fiftyTwoWeekHigh": 0.36,
  "forwardPE": null,
  "fromCurrency": null,
  "fiveYearAvgDividendYield": null,
  "fiftyTwoWeekLow": 0.02,
  "bid": 0.38,
  "tradeable": false,
  "dividendYield": null,
  "bidSize": 3000,
  "dayHigh": 0.34,
  "exchange": "PNK",
  "shortName": "ENZON PHARMACEUTICALS INC",
  "longName": "Enzon Pharmaceuticals, Inc.",
  "exchangeTimezoneName": "America/New_York",
  "exchangeTimezoneShortName": "EST",
  "isEsgPopulated": false,
  "gmtOffSetMilliseconds": "-18000000",
  "underlyingSymbol": null,
  "quoteType": "EQUITY",
  "symbol": "ENZN",
  "underlyingExchangeSymbol": null,
  "headSymbol": null,
  "messageBoardId": "finmb_269599",
  "uuid": "0587b8b7-aa7f-39dd-a561-8adfc18ffdbb",
  "market": "us_market",
  "annualHoldingsTurnover": null,
  "enterpriseToRevenue": 292.912,
  "beta3Year": null,
  "profitMargins": 0,
  "enterpriseToEbitda": null,
  "52WeekChange": null,
  "morningStarRiskRating": null,
  "forwardEps": null,
  "revenueQuarterlyGrowth": null,
  "sharesOutstanding": 74214600,
  "fundInceptionDate": null,
  "annualReportExpenseRatio": null,
  "bookValue": 0.117,
  "sharesShort": 157472,
  "sharesPercentSharesOut": 0.0036000002,
  "fundFamily": null,
  "lastFiscalYearEnd": 1577750400,
  "heldPercentInstitutions": 0.54652,
  "netIncomeToCommon": -1147000,
  "trailingEps": -0.026,
  "lastDividendValue": null,
  "SandP52WeekChange": null,
  "priceToBook": 2.6923077,
  "heldPercentInsiders": 0.108500004,
  "nextFiscalYearEnd": 1640908800,
  "mostRecentQuarter": 1601424000,
  "shortRatio": 1.03,
  "sharesShortPreviousMonthDate": 1459382400,
  "floatShares": 30105896,
  "enterpriseValue": 19625106,
  "threeYearAverageReturn": null,
  "lastSplitDate": 1506643200,
  "lastSplitFactor": "1:1",
  "legalType": null,
  "morningStarOverallRating": null,
  "earningsQuarterlyGrowth": null,
  "dateShortInterest": 1461888000,
  "pegRatio": null,
  "lastCapGain": null,
  "shortPercentOfFloat": 0.0041,
  "sharesShortPriorMonth": 507664,
  "category": null,
  "fiveYearAverageReturn": null,
  "regularMarketPrice": 0.34,
  "logo_url": "https://logo.clearbit.com/enzon.com"
}